Tumor Detection and Diagnosis Based on Biomarker
A special issue of Biosensors (ISSN 2079-6374). This special issue belongs to the section "Biosensors and Healthcare".
Deadline for manuscript submissions: closed (30 November 2023) | Viewed by 4597
Special Issue Editor
Interests: chemicobiology; pharmacochemistry; multi-omics
Special Issues, Collections and Topics in MDPI journals
Special Issue Information
Dear Colleagues,
Tumors are the second-largest cause of mortality in the world. The early detection and diagnosis of a tumor can effectively reduce its occurrence and fatality rate. Cancer biomarkers are molecules that are present in human blood, urine, or saliva as well as in other bodily fluids, tissues, and cells that are used to identify various tumors and to monitor tumor progression. The discovery of tumor biomarkers, namely nucleic acids, proteins, small-molecule metabolites, and microorganisms, can be applied to the detection, diagnosis, and prognosis of tumors because of their high sensitivity and specificity and non-invasive nature. Furthermore, the development of novel, simple, highly sensitive, and specific biomarker detection techniques is also significant for the use of biomarkers in tumor detection. Therefore, this new Special Issue focuses on the publication of scientific papers about tumor-related biomarkers as well as novel analytical methods and technologies for cancer detection.
We kindly invite the submission of original research and review articles about novel tumor biomarkers and biosensor technologies for tumor detection, diagnosis, prognosis, and monitoring.
Prof. Dr. Yuyang Jiang
Guest Editor
Manuscript Submission Information
Manuscripts should be submitted online at www.mdpi.com by registering and logging in to this website. Once you are registered, click here to go to the submission form. Manuscripts can be submitted until the deadline. All submissions that pass pre-check are peer-reviewed. Accepted papers will be published continuously in the journal (as soon as accepted) and will be listed together on the special issue website. Research articles, review articles as well as short communications are invited. For planned papers, a title and short abstract (about 100 words) can be sent to the Editorial Office for announcement on this website.
Submitted manuscripts should not have been published previously, nor be under consideration for publication elsewhere (except conference proceedings papers). All manuscripts are thoroughly refereed through a single-blind peer-review process. A guide for authors and other relevant information for submission of manuscripts is available on the Instructions for Authors page. Biosensors is an international peer-reviewed open access monthly journal published by MDPI.
Please visit the Instructions for Authors page before submitting a manuscript. The Article Processing Charge (APC) for publication in this open access journal is 2700 CHF (Swiss Francs). Submitted papers should be well formatted and use good English. Authors may use MDPI's English editing service prior to publication or during author revisions.
Keywords
- biosensors
- tumor biomarker
- tumor diagnosis
- tumor prognosis
- tumor monitoring
- liquid biopsy
- non-invasion
Benefits of Publishing in a Special Issue
- Ease of navigation: Grouping papers by topic helps scholars navigate broad scope journals more efficiently.
- Greater discoverability: Special Issues support the reach and impact of scientific research. Articles in Special Issues are more discoverable and cited more frequently.
- Expansion of research network: Special Issues facilitate connections among authors, fostering scientific collaborations.
- External promotion: Articles in Special Issues are often promoted through the journal's social media, increasing their visibility.
- e-Book format: Special Issues with more than 10 articles can be published as dedicated e-books, ensuring wide and rapid dissemination.
Further information on MDPI's Special Issue polices can be found here.